Neoadjuvant chemotherapy followed by radiotherapy should not be a standard approach for locally advanced cervical cancer

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 4, 1998, Pages 889-896

  Shueng, Pei Wei ^a   Hsu, Wen Lin ^a   Jen, Yee Min ^a   Wu, Ching Jung ^a   Liu, Hang Seng ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Cisplatin based regimens; Locally advanced cervical cancer; Radiotherapy (RT) neoadjuvant chemotherapy (CT); Randomized trial

Indexed keywords

CISPLATIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; GYNECOLOGIC CANCER; HUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IFOSFAMIDE; MESNA; MITOMYCINS; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS; UTERINE CERVICAL NEOPLASMS; VINCRISTINE;

EID: 0031945947     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00906-1     Document Type: Article

References (41)

1. Ludgate S. M., Crandon A. J., Hudson C. N., Walker Q., Langlands A. O. Synchronous 5-FU, mitomycin-C and radiation therapy in the treatment of locally advanced carcinoma of the cervix. Int. J. Radiat. Oncol. Biol. Phys. 15:1988;893-899.
2. Perez C. A. Uterine cervix. Perez C. A., Brady L. W. Principles and practice of radiation oncology. 1992;1178-1179 Lippincott Co, Philadelphia, PA.
3. Deppe G., Malviya V. K., Han I. A preliminary report of combination chemotherapy with cisplatin and mitomycin-C followed by radical hysterectomy or radiation therapy in patients with locally advanced cancer. Gynecol. Oncol. 42:1991;178-181.
4. Watson E. R., Halnan K. E., Constable W. Hyperbaric oxygen and radiotherapy A Medical Research Council trial in carcinoma of the cervix . Br. J. Radiol. 51:1978;879-887.
5. Report of MRC Working Party on the use of misonidazole in the treatment of carcinoma of the cervix. Br. J. Radiol. 57:1984;491-499.
6. Maor M. H., Gillespie B. W., Peters L. J. Neutron therapy in cervical cancer Result of a phase III RTOG study . Int. J. Radiat. Oncol. Bio. Phys. 14:1988;885-891.
7. Hornback N. B., Shupe R. E., Shidnia H., Marshall C. V., Lauer T. Advanced stage 3B cancer of cervix treatment by hyperthermia and radiation. Gynecol. Oncol. 23:1986;160-167.
8. Friedlander M. L., Atkinson K., Coppleson J. V. The integration of chemotherapy into the management of locally advanced cervical cancer A pilot study . Gynecol. Oncol. 19:1984;1-7.
9. Bloss J. D., Lucci J. A. III, DiSala P. J. A phase II trial of neoadjuvant chemotherapy prior to radical hysterectomy and/or radiation therapy in the management of advanced carcinoma of the uterine cervix. Gynecol. Oncol. 59:1995;105-110.
10. Dische S. Hyperbaric oxygen The Medical Research Council trials and their clinical significance . Br. J. Radiol. 51:1978;888-894.
11. Kirsten F., Atkinson K. H., Coppleson J. V. Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer. Br. J. Obstet. Gynaecol. 94:1987;583-588.
12. Kuehnle H., Meerpohl H.-G., Eiermann W., et al. Phase II study of carboplatin/ifosfamide in untreated cervical cancer. Cancer Chemother. Pharmacol. 26:(Suppl.):1990;33-35.
13. Lara P. C., Garcia-Puche J. L., Pedraza V. Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma. Cancer Chemother. Pharamcol. 26:(Suppl.):1990;S36-S38.
14. Lipsztein R., Kredentser D., Dottino P. Combined chemotherapy and radiation therapy for advanced carcinoma of the cervix. Am. J. Clin. Oncol. (CCT). 10:1987;527-530.
15. Rabinovich M. G., Focaccia G., Ferreyra R., Elem Y., Leone B. A., Vallejo C. T. Neoadjuvant chemotherapy for cervical carcinoma. Obstet. Gynecol. 78:1991;685-688.
16. Sardi J., Sanaces C., Giaroli A., Maya G., Di Paola G. R. Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol. Oncol. 38:1990;486-493.
17. Symonds R. P., Burnett R. A., Habeshaw T., Kaye S. B., Snee M. P., Watson E. R. The prognostic value of chemotherapy given before radiotherapy in advanced cancer of cervix. Br. J. Cancer. 50:1989;473-475.
18. Tobias J., Buxton E. J., Blackledge G., Mould J. J., Spooner D., Chetiyawardana A. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer. Cancer Chemother. Pharmacol. 26:(Suppl.):1990;59-62.
19. Volterrani F., Tana S., Lozza L. Sequential chemotherapy-radiotherapy in the treatment of advanced cervical carcinoma. Cervix Lower Female Genital. Tract. 8:1987;217-222.
20. Weiner S. A., Aristizabal S., Alberts D. S., Surwit E. A., Deatherage-Deuser K. A phase II trial of mitomycin vincristine, bleomycin and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical cancer. Gynecol. Oncol. 30:1988;1-6.
21. Zanetta G., Landoni F., Columbo A., Pellegrino A., Maneo A., Leventis C. Three-year results after neoadjuvant chemotherapy, radical surgery, and radiotherapy in locally advanced cervical carcinoma. Obstet. Gynecol. 82:1993;447-450.
22. Cardenas J., Olguin J., Figurroa F., Bercerra F., Huizar R. M. Randomized neoadjuvant chemotherapy in cervical carcinoma stage IIB PEC + RT vs RT . Proc. Annu. Meet. Am. Soc. Clin. Oncol. 10:1991;A620.
23. Cardenas J., Ogluin A., Figueroa F., Pena J., Huizar R., Becererra F. Neoadjuvant chemotherapy (CT) + Radiotherapy (RT) vs alone in stage IIIb cervical carcinoma Priliminary results . Proc. Annu. Meet. Am. Soc. Clin. Oncol. 11:1992;A743.
24. Chauvergne J., Rohart J., Heron J. Randomized phase III trial of neoadjuvant chemotherapy (CT) + radiotherapy (RT) vs RT in stage IIB, III carcinoma of cervix A cooperative study of the French Oncology Centres . Proc. Annu. Meet. Am. Soc. Clin. Oncol. 7:1988;A524.
25. Chiara S., Bruzzone M., Merlini L. Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIb-III cervical carcinoma. Am. J. Clin. Oncol. 17:1994;294-297.
26. Kumar L., Kaushal R., Nandy M. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer A randomized study . Gynecol. Oncol. 54:1994;307-315.
27. Souhami L., Gil R. A., Allan S. Randomized trial of chemotherapy followed by pelvic radiotherapy versus radiotherapy alone in state IIIB carcinoma of the cervix. J. Clin. Oncol. 9:1991;970-977.
28. Tattersall M. H. N., Ramirez C., Coppleson M. A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer. Int. J. Gyneco. Cancer. 2:1992;244-251.
29. Tattersall M. H. N., Lorvidhaya V., Vootiprux V. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. J. Clin. Oncol. 13:1995;444-451.
30. Park R. C., Thigpen J. T. Chemotherapy in advanced and recurrent cervical cancer A review . Cancer. 71:(Suppl.):1993;1446-1450.
31. Erazo-Valle, A.; Torreciollas, L.; Cervantes, G. A phase II trial of neoadjuvant chemotherapy (CHT) with ifosfamide, mesna and cisplatin (IMESPLA) in stage IIa-IIIb cervical cancer. Proc. Int. Congr. Anticancer Chemother. 89:1993.
32. Haie C., George M., Pejovic M. H. Feasibility study of an alternating schedule of radiotherapy and chemotherapy in advanced uterine cervical carcinoma. Radiother. Oncol. 12:1988;121-127.
33. Kuehnle H., Meerpohl H.-G., Eiermann W., Achterrath W. Neoadjuvant therapy for cervical cancer. Semin. Oncol. 19:(Suppl 2):1992;94-98.
34. Vermoken J. B. The role of chemotherapy in squamous cell carcinoma of the uterine cervix A review . Int. J. Gynecol. Cancer. 3:1993;129-142.
35. Ozols R. F., Masuda H., Hamilton T. C. Keynote address Mechanisms of cross-resistance between radiation and neoplastic drugs . NCI Monogr. 6:1988;159-165.
36. Withers H. R., Taylor J. M. F., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta. Oncol. 27:1988;131-146.
37. Potish R. A., Twiggs L. B. On the lack of demonstrated clinical benefit of neoadjuvant cisplatinum therapy for cervical cancer. Int. J. Radiat. Oncol. Biol. Phys. 27:1993;975-979.
38. Hreschyshyn M. M., Aron B. S., Boronow R. C., Franlin E. W., Shingleton H. M., Blessing J. A. Hydroxyurea or placebo combined with radiation to treat stage IIIB and IV cervical cancer confined to the pelvis. Int. J. Radiat. Oncol. Biol. Phys. 5:1979;317-322.
39. Munro A. J. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br. J. Cancer. 71:1995;83-91.
40. Thigpen T., Vance R. B., Khansur T. Carcinoma of the uterine cervix Current status and future directions . Semin. Oncol. 21:(Suppl. 2):1994;43-54.
41. Kigawa J., Minagawa Y., Ishihara H. The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer. Am. J. Clin. Oncol. 19:1996;255-259.